Kelly Mousa

Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial

Thomas Powles, Mark Kockx, Alejo Rodríguez‐Vida et al. · Nature Medicine · 2019 · 555 citations · Full text

Urology, Biomarker Analysis, Genitourinary Cancer +7

Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial

Peter Schmid, Jacinta Abraham, Stephen Chan et al. · Journal of Clinical Oncology · 2019 · 373 citations · Full text

Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer

Hemant M. Kocher, Bristi Basu, Fieke E. M. Froeling et al. · Nature Communications · 2020 · 191 citations · Full text

Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder

Bernadett Szabados, Mark Kockx, Zoe J. Assaf et al. · European Urology · 2022 · 175 citations

Urology, Genitourinary Cancer, Muscle-invasive Urothelial Cancer +7

NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer

Carlo Palmieri, Susan Cleator, Lucy Kilburn et al. · Breast Cancer Research and Treatment · 2014 · 100 citations

Breast Oncology, Endocrine-related Cancer, Neoadjuvant Endocrine Therapy +7